Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nursing Homes | 56 | 2024 | 1081 | 11.790 |
Why?
|
Hip Fractures | 41 | 2024 | 988 | 10.800 |
Why?
|
Accidental Falls | 30 | 2024 | 1066 | 5.530 |
Why?
|
Homes for the Aged | 13 | 2021 | 272 | 3.710 |
Why?
|
Osteoporosis | 15 | 2022 | 1603 | 3.390 |
Why?
|
Bone Density Conservation Agents | 11 | 2022 | 795 | 3.300 |
Why?
|
Frail Elderly | 12 | 2023 | 761 | 2.690 |
Why?
|
Skilled Nursing Facilities | 10 | 2024 | 395 | 2.550 |
Why?
|
Nursing Staff | 3 | 2023 | 113 | 2.230 |
Why?
|
Osteoporotic Fractures | 8 | 2023 | 411 | 2.180 |
Why?
|
Medicare | 31 | 2024 | 6732 | 1.760 |
Why?
|
Long-Term Care | 8 | 2023 | 633 | 1.730 |
Why?
|
Diphosphonates | 5 | 2020 | 636 | 1.550 |
Why?
|
Fractures, Bone | 8 | 2022 | 2045 | 1.250 |
Why?
|
Aged, 80 and over | 58 | 2024 | 58859 | 1.240 |
Why?
|
Dementia | 7 | 2023 | 2679 | 1.120 |
Why?
|
Aged | 80 | 2024 | 168840 | 1.030 |
Why?
|
Hypnotics and Sedatives | 4 | 2019 | 1177 | 0.930 |
Why?
|
Geriatric Assessment | 6 | 2020 | 1409 | 0.840 |
Why?
|
United States | 43 | 2024 | 72202 | 0.810 |
Why?
|
Activities of Daily Living | 8 | 2023 | 2420 | 0.810 |
Why?
|
Hospitalization | 9 | 2023 | 10698 | 0.800 |
Why?
|
Independent Living | 4 | 2024 | 579 | 0.790 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2024 | 1240 | 0.780 |
Why?
|
Bone Density | 7 | 2023 | 3549 | 0.780 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2018 | 0.770 |
Why?
|
Hypoglycemia | 3 | 2024 | 884 | 0.750 |
Why?
|
Allied Health Personnel | 2 | 2022 | 155 | 0.740 |
Why?
|
Urinary Tract Infections | 2 | 2024 | 806 | 0.700 |
Why?
|
Wounds and Injuries | 5 | 2023 | 2483 | 0.680 |
Why?
|
Retrospective Studies | 34 | 2024 | 80430 | 0.660 |
Why?
|
Risk Assessment | 15 | 2024 | 23953 | 0.650 |
Why?
|
Female | 77 | 2024 | 391875 | 0.650 |
Why?
|
Male | 70 | 2024 | 360035 | 0.640 |
Why?
|
Humans | 114 | 2024 | 760437 | 0.640 |
Why?
|
Terminal Care | 2 | 2021 | 1751 | 0.630 |
Why?
|
Vaccination | 6 | 2023 | 3375 | 0.630 |
Why?
|
Disabled Persons | 2 | 2018 | 1224 | 0.600 |
Why?
|
Pelvic Bones | 1 | 2019 | 270 | 0.570 |
Why?
|
Risk Management | 1 | 2020 | 557 | 0.570 |
Why?
|
Drug Utilization Review | 1 | 2017 | 248 | 0.540 |
Why?
|
Cholinesterase Inhibitors | 2 | 2024 | 241 | 0.540 |
Why?
|
Length of Stay | 3 | 2024 | 6413 | 0.530 |
Why?
|
Health Services for the Aged | 1 | 2018 | 259 | 0.520 |
Why?
|
Risk Factors | 30 | 2024 | 74055 | 0.510 |
Why?
|
Analgesics | 2 | 2024 | 1070 | 0.510 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.490 |
Why?
|
Perception | 1 | 2021 | 1196 | 0.480 |
Why?
|
Quality Improvement | 2 | 2021 | 3798 | 0.470 |
Why?
|
Drug Prescriptions | 2 | 2013 | 1669 | 0.450 |
Why?
|
Advance Care Planning | 1 | 2021 | 694 | 0.440 |
Why?
|
Child Health Services | 1 | 2018 | 645 | 0.420 |
Why?
|
Disease Outbreaks | 2 | 2022 | 1762 | 0.420 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12127 | 0.410 |
Why?
|
Sulfonylurea Compounds | 3 | 2023 | 219 | 0.410 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2750 | 0.410 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2008 | 0.390 |
Why?
|
Checklist | 1 | 2018 | 827 | 0.380 |
Why?
|
Cohort Studies | 15 | 2023 | 41366 | 0.380 |
Why?
|
Cross-Over Studies | 5 | 2017 | 2073 | 0.370 |
Why?
|
Postural Balance | 4 | 2024 | 621 | 0.370 |
Why?
|
Lower Extremity | 1 | 2019 | 1199 | 0.370 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 152 | 0.360 |
Why?
|
Alendronate | 2 | 2018 | 175 | 0.360 |
Why?
|
Memantine | 1 | 2011 | 108 | 0.360 |
Why?
|
Dopamine Agents | 1 | 2011 | 189 | 0.350 |
Why?
|
Nootropic Agents | 1 | 2011 | 157 | 0.350 |
Why?
|
Health Promotion | 1 | 2022 | 2211 | 0.340 |
Why?
|
Anticoagulants | 2 | 2024 | 4806 | 0.340 |
Why?
|
Benzodiazepines | 1 | 2015 | 1130 | 0.330 |
Why?
|
Diuretics | 1 | 2012 | 610 | 0.320 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5126 | 0.320 |
Why?
|
Syncope | 1 | 2011 | 427 | 0.310 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1416 | 0.310 |
Why?
|
Absorptiometry, Photon | 5 | 2023 | 1736 | 0.300 |
Why?
|
Teriparatide | 2 | 2021 | 227 | 0.290 |
Why?
|
Influenza, Human | 1 | 2018 | 1517 | 0.290 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1736 | 0.290 |
Why?
|
Psychotropic Drugs | 1 | 2013 | 888 | 0.290 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2021 | 311 | 0.280 |
Why?
|
Stroke | 3 | 2024 | 9745 | 0.270 |
Why?
|
Subacute Care | 3 | 2023 | 178 | 0.270 |
Why?
|
Intensive Care Units | 1 | 2019 | 3742 | 0.270 |
Why?
|
Incidence | 9 | 2020 | 21322 | 0.260 |
Why?
|
Pandemics | 5 | 2023 | 8623 | 0.250 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14565 | 0.240 |
Why?
|
Osteoporosis, Postmenopausal | 2 | 2018 | 396 | 0.240 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11453 | 0.230 |
Why?
|
Thiazides | 1 | 2023 | 19 | 0.230 |
Why?
|
Age Factors | 6 | 2020 | 18379 | 0.230 |
Why?
|
Amlodipine | 1 | 2023 | 84 | 0.220 |
Why?
|
Hypertension | 1 | 2023 | 8527 | 0.220 |
Why?
|
Femur Neck | 2 | 2018 | 314 | 0.210 |
Why?
|
Vaccines | 2 | 2022 | 836 | 0.210 |
Why?
|
Geriatrics | 3 | 2019 | 388 | 0.210 |
Why?
|
Glipizide | 1 | 2022 | 48 | 0.210 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3220 | 0.210 |
Why?
|
Antidepressive Agents | 2 | 2013 | 2897 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2017 | 10759 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1517 | 0.200 |
Why?
|
Review Literature as Topic | 1 | 2024 | 347 | 0.200 |
Why?
|
Glyburide | 1 | 2022 | 116 | 0.200 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3066 | 0.200 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3076 | 0.190 |
Why?
|
Assisted Living Facilities | 1 | 2021 | 27 | 0.190 |
Why?
|
Medication Adherence | 2 | 2010 | 2166 | 0.190 |
Why?
|
Pharmaceutical Services | 1 | 2023 | 141 | 0.190 |
Why?
|
Analgesics, Opioid | 3 | 2024 | 3792 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Pharmacies | 1 | 2023 | 169 | 0.180 |
Why?
|
Age Distribution | 3 | 2017 | 2878 | 0.170 |
Why?
|
Hearing Aids | 1 | 2020 | 58 | 0.170 |
Why?
|
Pilot Projects | 3 | 2023 | 8611 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6471 | 0.160 |
Why?
|
Sex Factors | 4 | 2019 | 10538 | 0.160 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 168 | 0.160 |
Why?
|
Heart Failure | 1 | 2023 | 11653 | 0.160 |
Why?
|
Meta-Analysis as Topic | 1 | 2024 | 1376 | 0.160 |
Why?
|
Logistic Models | 4 | 2017 | 13240 | 0.160 |
Why?
|
Pneumonia, Aspiration | 1 | 2019 | 145 | 0.160 |
Why?
|
Sex Distribution | 2 | 2017 | 2281 | 0.160 |
Why?
|
Time Factors | 6 | 2019 | 39947 | 0.160 |
Why?
|
Comorbidity | 4 | 2019 | 10494 | 0.160 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12054 | 0.160 |
Why?
|
Resistance Training | 1 | 2021 | 193 | 0.160 |
Why?
|
Odds Ratio | 3 | 2019 | 9639 | 0.150 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 168 | 0.150 |
Why?
|
Life Expectancy | 2 | 2019 | 1240 | 0.150 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15476 | 0.150 |
Why?
|
New Hampshire | 1 | 2018 | 173 | 0.150 |
Why?
|
Dehydration | 1 | 2019 | 216 | 0.150 |
Why?
|
Medicare Part D | 1 | 2023 | 355 | 0.150 |
Why?
|
Policy | 1 | 2022 | 508 | 0.150 |
Why?
|
Soft Tissue Injuries | 1 | 2019 | 172 | 0.150 |
Why?
|
Irritable Bowel Syndrome | 1 | 2023 | 455 | 0.150 |
Why?
|
Calcitonin | 1 | 2018 | 329 | 0.140 |
Why?
|
Communication | 3 | 2022 | 3868 | 0.140 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12429 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 3975 | 0.140 |
Why?
|
Calibration | 1 | 2019 | 818 | 0.140 |
Why?
|
Obesity | 1 | 2019 | 12918 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3190 | 0.130 |
Why?
|
Boston | 3 | 2022 | 9326 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2017 | 39078 | 0.130 |
Why?
|
Middle Aged | 11 | 2024 | 220382 | 0.130 |
Why?
|
New Zealand | 3 | 2021 | 357 | 0.120 |
Why?
|
Models, Economic | 1 | 2019 | 716 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 763 | 0.120 |
Why?
|
Mobility Limitation | 1 | 2019 | 408 | 0.120 |
Why?
|
Aging | 3 | 2022 | 8689 | 0.120 |
Why?
|
HIV Infections | 1 | 2021 | 17328 | 0.120 |
Why?
|
Reward | 1 | 2021 | 970 | 0.120 |
Why?
|
Sarcopenia | 1 | 2019 | 372 | 0.120 |
Why?
|
Documentation | 1 | 2021 | 895 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3421 | 0.120 |
Why?
|
Geography | 1 | 2016 | 658 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4567 | 0.110 |
Why?
|
Home Care Services | 2 | 2019 | 647 | 0.110 |
Why?
|
Peer Group | 1 | 2019 | 684 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 809 | 0.110 |
Why?
|
Prognosis | 3 | 2019 | 29551 | 0.110 |
Why?
|
Pneumonia | 2 | 2019 | 2140 | 0.110 |
Why?
|
Moving and Lifting Patients | 1 | 2013 | 18 | 0.110 |
Why?
|
Health Personnel | 3 | 2022 | 3331 | 0.110 |
Why?
|
Hospice Care | 1 | 2019 | 677 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2021 | 22097 | 0.100 |
Why?
|
Hearing Loss | 1 | 2020 | 781 | 0.100 |
Why?
|
Massachusetts | 3 | 2017 | 8826 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2024 | 1918 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 991 | 0.100 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2012 | 78 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10180 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 699 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1925 | 0.100 |
Why?
|
Motivation | 1 | 2021 | 2006 | 0.100 |
Why?
|
Administration, Oral | 2 | 2023 | 4010 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2020 | 1847 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1117 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 22083 | 0.090 |
Why?
|
Acute Disease | 2 | 2012 | 7230 | 0.090 |
Why?
|
Refusal to Participate | 1 | 2010 | 31 | 0.090 |
Why?
|
Survival Rate | 2 | 2018 | 12698 | 0.090 |
Why?
|
Epidemiologic Methods | 2 | 2012 | 1336 | 0.090 |
Why?
|
Testosterone | 1 | 2021 | 2471 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2024 | 4789 | 0.080 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 619 | 0.080 |
Why?
|
Internet | 1 | 2021 | 3092 | 0.080 |
Why?
|
Outpatients | 1 | 2017 | 1596 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4849 | 0.080 |
Why?
|
Rehabilitation Centers | 1 | 2010 | 248 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2603 | 0.080 |
Why?
|
Recurrence | 3 | 2012 | 8466 | 0.080 |
Why?
|
Hospitals | 1 | 2021 | 3873 | 0.070 |
Why?
|
Patient Discharge | 2 | 2023 | 3436 | 0.070 |
Why?
|
Pressure Ulcer | 1 | 2009 | 156 | 0.070 |
Why?
|
Psychological Tests | 1 | 2010 | 640 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 487 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5874 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2367 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 64591 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2545 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5491 | 0.070 |
Why?
|
Environment | 1 | 2012 | 1122 | 0.060 |
Why?
|
Sepsis | 1 | 2019 | 2583 | 0.060 |
Why?
|
Cognition | 3 | 2021 | 6973 | 0.060 |
Why?
|
Intelligence | 1 | 2010 | 924 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3923 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7948 | 0.060 |
Why?
|
Cholecalciferol | 1 | 2010 | 552 | 0.060 |
Why?
|
Prospective Studies | 5 | 2013 | 54339 | 0.060 |
Why?
|
Dietary Proteins | 1 | 2010 | 953 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3880 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2925 | 0.060 |
Why?
|
Muscle Strength | 1 | 2008 | 623 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2927 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3344 | 0.060 |
Why?
|
Adult | 3 | 2022 | 220781 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4586 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13338 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1906 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4923 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2022 | 12785 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20078 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15257 | 0.050 |
Why?
|
Vitamins | 1 | 2010 | 1635 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 189 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2021 | 88 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6230 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3155 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15698 | 0.040 |
Why?
|
Regression Analysis | 1 | 2010 | 6340 | 0.040 |
Why?
|
Calcium | 2 | 2010 | 5726 | 0.040 |
Why?
|
Drug Interactions | 1 | 2024 | 1415 | 0.040 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 39 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2022 | 368 | 0.040 |
Why?
|
Anemia | 1 | 2009 | 1508 | 0.040 |
Why?
|
Maryland | 1 | 2019 | 276 | 0.040 |
Why?
|
Vitamin D | 2 | 2010 | 3303 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3686 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5866 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9605 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 703 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1245 | 0.040 |
Why?
|
Constipation | 1 | 2023 | 562 | 0.040 |
Why?
|
Depression | 2 | 2020 | 8104 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 130 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1750 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7380 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1589 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4240 | 0.040 |
Why?
|
Mass Screening | 1 | 2013 | 5424 | 0.040 |
Why?
|
Canada | 1 | 2022 | 2119 | 0.040 |
Why?
|
Mortality | 1 | 2008 | 2897 | 0.030 |
Why?
|
Diarrhea | 1 | 2023 | 1319 | 0.030 |
Why?
|
Indians, North American | 1 | 2019 | 353 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1404 | 0.030 |
Why?
|
Coronary Disease | 1 | 2009 | 5919 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 848 | 0.030 |
Why?
|
Androgens | 1 | 2021 | 1282 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1942 | 0.030 |
Why?
|
Delirium | 1 | 2024 | 1667 | 0.020 |
Why?
|
Patient Participation | 1 | 2021 | 1442 | 0.020 |
Why?
|
Qualitative Research | 1 | 2022 | 3008 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3414 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4342 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12932 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2975 | 0.020 |
Why?
|
Accidents, Home | 1 | 2010 | 71 | 0.020 |
Why?
|
Diet | 2 | 2023 | 8058 | 0.020 |
Why?
|
Child | 1 | 2018 | 80086 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26063 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3249 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2757 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3782 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2421 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4383 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15627 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 968 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2012 | 2683 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 3027 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2691 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7817 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 14002 | 0.000 |
Why?
|
Concepts
(285)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_